This basic science study demonstrates that a significant proportion (40%) of blood anti-urokinase is localized within platelets, compared to only 3% of antiplasmin.
Answers are grounded in this paper and cite their sources.
Supports investigation of platelet antiurokinase in fibrinolysis; leaves open clinical relevance pending human data.
Summary Direct antiplasmin and anti-urokinase can be measured with artificial clots to which plasma, serum or platelet suspension is added incubated in plasmin or urokinase respectively. Whilst only 3% of the total antiplasmin in the blood is present in the platelets, there is 40% of the total antiurokinase present in the platelets. The properties of this thrombocytic anti-urokinase are discussed. Only 60% is soluble in water. By heating this solution the inhibiting effect increases. Platelet anti-activator is also active against other activators but has not the same properties as anti-urokinase. Implications of these findings are discussed.
No takes yet. Share an insight, caveat, or question.
Ottolander et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: